Pyridoxal 5ꞌ-phosphate-responsive epilepsy with novel mutations in the PNPO gene: a case report.

Genet Mol Res

Center of Excellence for Medical Genetics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Published: October 2015

Pyridoxal 5'-phosphate (PLP)-responsive epilepsy is a rare autosomal recessive epileptic disorder caused by deficiency of pyridox(am)-ne 5'-phosphate oxidase (PNPO). Neonatal onset seizures in PLP responsive epilepsy are usually resistant to common anticonvulsants and pyridoxine, but respond to PLP. Various PNPO mutations are associated with this disorder. In this report, we have described a case of a female baby with neonatal onset seizures responding to PLP. Exome sequencing revealed that the patient was compound heterozygous for pathogenic mutations [c.546+1G>A (IVS5+1 G>A) and c.620delG (p.G207VfsX215)] in the PNPO gene. The c.546+1G>A was inherited from the mother while the c.620delG was inherited from the father. Both mutations were absent in 122 unrelated Thai controls. The results of this study indicated the presence of two newly identified mutations in this Thai patient with PLP-responsive epilepsy for the first time, expanding the mutational spectrum of PNPO.

Download full-text PDF

Source
http://dx.doi.org/10.4238/2015.October.29.34DOI Listing

Publication Analysis

Top Keywords

pnpo gene
8
plp-responsive epilepsy
8
neonatal onset
8
onset seizures
8
mutations
5
pnpo
5
pyridoxal 5ꞌ-phosphate-responsive
4
epilepsy
4
5ꞌ-phosphate-responsive epilepsy
4
epilepsy novel
4

Similar Publications

Multiple myeloma (MM) is a cancer of plasma cells caused by abnormal gene expression and interactions within the bone marrow (BM) niche. The BM environment significantly influences the progression of MM. Celastrol, a natural compound derived from traditional Chinese medicine, exhibits significant anticancer effects.

View Article and Find Full Text PDF

Pyridoxal 5'-phosphate (PLP), the catalytically active form of vitamin B, acts as a cofactor in many metabolic processes. In humans, PLP is produced in the reactions catalysed by pyridox(am)ine 5'-phosphate oxidase (PNPO) and pyridoxal kinase (PDXK). Both PNPO and PDXK are involved in cancer progression of many tumours.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored the use of next-generation sequencing (NGS) to identify genetic variants in 55 children with childhood epilepsy of unknown origins, ultimately diagnosing about 50.9% of the cases.* -
  • Researchers found variants in 22 different epilepsy-associated genes, with significant findings related to SCN1A, ALDH7A1, and KCNQ2, which could inform targeted therapies for some patients.* -
  • The discovery of novel genetic variants enhances the understanding of the genetic factors linked to childhood epilepsy and aims to improve diagnosis and treatment strategies globally.*
View Article and Find Full Text PDF
Article Synopsis
  • - Vitamin B6 is essential for DNA and amino acid metabolism, with its active form, pyridoxal 5'-phosphate (PLP), showing a potential link to lower cancer risk, although specific dietary evidence is inconsistent.
  • - Research indicates that a deficiency in PLP can cause DNA damage and promote tumor growth in fruit flies, with studies showing that supplementing with PLP can reduce tumor development.
  • - The study highlights the connection between low PLP levels, increased genome instability, and cancer development through mechanisms involving reactive oxygen species (ROS) and impaired DNA repair processes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!